Original Steelman
The claim rests on a clear causal chain: publicly funded research is a public good, and removing paywalls reduces information frictions. OA requirements expand access for researchers, clinicians, educators, entrepreneurs, and the public—especially those outside well-resourced universities—thereby increasing the pool of potential users who can build on findings. Wider and faster dissemination can reduce duplication, accelerate cumulative science, and improve cross-disciplinary recombination, which are common drivers of innovation. Equity improves because benefits of publicly funded knowledge are not limited to institutions that can afford subscriptions; learners and practitioners in lower-income settings gain comparable access to the literature. OA mandates can also standardize sharing norms and ensure long-term availability through repositories, making access less dependent on individual authors’ choices. If paired with appropriate funding and waiver policies, OA can broaden participation in both producing and using research outputs, supporting more inclusive innovation ecosystems.
Counter-Argument Steelman
The claim may overgeneralize from plausible mechanisms to broad outcomes. Open-access (OA) mandates can increase readership, but innovation depends on complementary factors (absorptive capacity, R&D investment, IP strategy, and industry-academia links). Many potential innovators—especially SMEs—may lack time, expertise, or data/code access to translate papers into products, so OA alone may have limited marginal effect. Equity gains are also uneven: OA often shifts costs from readers to authors via article processing charges (APCs), which can disadvantage underfunded researchers, institutions, and regions unless waivers or funding are robust. Mandates can also create compliance burdens and push researchers toward certain journals, potentially affecting career incentives. Additionally, “publicly funded research” is heterogeneous; in some fields, preprints or informal sharing already provide access, reducing incremental benefits. Finally, innovation may be constrained by patents, trade secrets, or restricted datasets; OA to articles may not unlock the key inputs needed for equitable downstream use.